Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future.

Abstract

The report by Curti et al. highlightsthe potential of NK cell-based adoptive cellular immunotherapy in oncology,currently boosted by advances in the knowledge on NK cell biology and in their ex-vivo GMP manipulation.Several issues deserve attention to fully achieve the translation of these advances to the clinic.